Oracle Introduces Oracle(r) Health Sciences Central Coding 3.0
Oracle today announced the availability of Oracle® Health Sciences Central Coding Release 3.0. The third generation of the Web-based clinical trial data coding and dictionary management application includes expanded query management and automated workflows that help clinical trial sponsors and contract research organizations (CROs) improve the efficiency and consistency of the coding process.
Oracle Health Sciences Central Coding Release 3.0 features enhanced integration with Oracle Health Sciences InForm Global Trial Management Global Trial Management system, which promotes greater productivity via improved query management and workflow. This release enables users to create and manage Oracle Health Sciences InForm Global Trial Management queries directly in Oracle Health Sciences Central Coding Release 3.0, streamlining the coding process with one point of entry to apply and manage coding updates to all Oracle Health Sciences InForm Global Trial Management-managed trials in process.
It features:
- A flexible, multilingual application that automates coding and minimizes the manual effort required to code verbatim terms, Oracle Health Sciences Central Coding Release 3.0 is the first coding solution to be certified by the Uppsala Monitoring Center, the World Health Organization collaborative center for international drug monitoring.
- A new user interface and simplified status information. Customizable flags and status options enable users to tailor and optimize their workflow.
- Auto-query, propagate, and auto-close tools enhance productivity by reducing the manual effort required to raise and resolve queries.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
